factually
Index/Topics/Low-dose Methylene Blue for Alzheimer's Disease

Low-dose Methylene Blue for Alzheimer's Disease

Investigation of low-dose methylene blue for Alzheimer's disease treatment, including its effects on cognition, function, and brain atrophy.

Fact-Checks

1 result
Jan 18, 2026
Most Viewed

What randomized clinical trials are underway testing low‑dose methylene blue for Alzheimer’s disease and what are their endpoints?

Low‑dose methylene blue (and its reduced proprietary forms LMTM/HMTM) remains under active clinical investigation for Alzheimer’s disease (AD) in a small set of randomized trials that focus on short‑t...